Hosam Darwish Abo Gad Alla

Dexrazoxane (Cardioxane) as cardio - protector from anthracycline cardiotoxicity in high risk cancer patients / استخدام عقار ديكسرازوكسان (كارديوكسان) للوقاية من اعتلال القلب الناتج عن استخدام الانثراسيكلين فى مرضى السرطان المعرضين للاصابة Hosam Darwish Abo Gad Alla ; Supervised Mostafa Mahmoud Elserafi , Nasr Mohamed Ali Allahloby , Mohamed Sayed Ahmed - Cairo : Hosam Darwish Abo Gad Alla , 2004 - 168P : diagrs ; 25cm

Thesis (PH.D.) - Cairo University - National Cancer Institute - Department Of Oncology

Anthracycline especially DOX are highly effective anti - neoplastic agent , so they widely used in treatment of large variety of malignant tumourThe most serious side effect of anthracycline is cardiotoxicity , the risk of cumulative toxic cardiomyopathy has an effect on the total dose of these drugs and reduce their therapeutic potential



Breast cancer Cardiac risk factors Dexrazoxane Doxorubicin cardiomyopathy